Yıl: 2021 Cilt: 28 Sayı: 8 Sayfa Aralığı: 1471 - 1476 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2020.09.922 İndeks Tarihi: 11-11-2021

Serum adiponectin levels in children with nonspecificinfections

Öz:
Aim: Adiponectin, which is mainly produced by adipocytes, has antidiabetic, antiatherosclerotic and anti-inflammatory activities. We analyzed serum adiponectin levels and their relationship with metabolic parameters, fever and acute phase reactants in children with nonspecific infections and tried to analyze whether adiponectin has a role in the processes of inflammation and fever during infections.Materials and Methods: In this study, we studied serum adiponectin levels in 42 prepubertal children admitted with fever≥38°C and symptoms of nonspecific infections. The children’s ideal body weights for their heights were within 100% and 110%. The venous blood samples were collected both in the first admission with fever and three days after the fever dropped (control visit) for the analysis of serum adiponectin levels, complete blood count, erythrocyte sedimentation rate, C reactive protein, High-sensitive CRP, fibrinogen, ferritin, glucose, and insulin levels. The glucose/insulin rate and Homeostasis model assessment of insulin resistance and body mass index were calculated.Results: The serum adiponectin levels of the children in the first admission were lower than those in the control visit (8.80±1.71µg/ml vs 12.04±2.38µg/ml)(p=0.000). The serum adiponectin levels were not correlated with the body temperature, body weight, ideal body weight for height, body mass index, Homeostasis model assessment of insulin resistance, and all other parameters analyzed in the study (p>0.05) in both admissions except the glucose/insulin ratio and leukocyte counts of the children in the first admission. The serum adiponectin levels were positively correlated with the glucose/insulin ratio and leukocyte counts in the first admission (r=0.338,p=0.029; r=0.304,p=0.05 respectively). Conclusion: It is not known why the serum adiponectin levels of the children were different in the admission with fever than those in the control visit during the recovery phase. The change in adiponectin levels during the acute infection have raised some questions regarding whether serum adiponectin levels may be an acute phase reactant and if it might be involved in the processes of inflammation and fever.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
  • 1. Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol 2016;8:93-100.
  • 2. Fisher FF. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diab 2005;48:1084-7.
  • 3. Berg AH, Combs TP, Du X, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-53.
  • 4. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6.
  • 5. Fallo F, Scarda A, Sonino N, et al. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. Eur J Endocrinol 2004;150:339-44.
  • 6. Lam KS, Xu A, Tan KC, et al. Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. J Clin Endocrinol Metab 2004;89:5448-53.
  • 7. Behre CJ, Gummesson A, Jernås M, et al. Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome. Metab 2007;56:1022-8.
  • 8. Matsuwaza Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis Supplements 2005;6:7-14.
  • 9. Tan KC, Xu A, Chow WS. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2004;89:765-9.
  • 10. Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003;278:45021-6.
  • 11. Maeda N, Shimomura I, Kishida K. Diet induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002;8:731-7.
  • 12. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab 2007;9:282-9.
  • 13. Ouchi N, Kihara S, Arita Y. Novel modulator for endothelial adhesion molecules: adipocytederived plasma protein adiponectin. Circulation 1999;100:2473-6.
  • 14. Wolf AM, Wolf D, Rumpold H, et al. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004;323:630-5.
  • 15. Uji Y, Yamamoto H, Tsuchihashi H, et al. Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. Surgery 2009;145:550-7.
  • 16. Rovin BH, Song H. Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin Immunol 2006;120:99-105.
  • 17. Saijo S, Nagata K, Nakano Y, et al. Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells. Biochem Biophys Res Commun 2005;334:1180-3.
  • 18. Petit JM, Minello A, Jooste V, et al. Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients. J Clin Endocrinol Metab 2005;90:2240-3.
  • 19. Liu CJ, Chen PJ, Jeng YM, et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J Hepatol 2005;43:235-42.
  • 20. Falasca K, Manigrasso MR, Racciatti D, et al. Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIVinfected patients. Ann Clin Lab Sci 2006;36:59-66.
  • 21. Singhal A, Jamieson N, Fewtrell M, et al. Adiponectin predicts ınsulin resistance but not endothelial function in young, healthy adolescents. J Clin Endocrinol Metab 2005;90:4615-21.
  • 22. Lawlor DA, Smith GD, Ebrahim S. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005;90:5677-83.
  • 23. Rothenbacher D, Brenner H, Marz W. Adiponectin risk of coronary heart disease and correlations with cardiovascular risk marker. Eur J Heart 2005;1-7.
  • 24. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-8.
  • 25. Gearhart MM, Parbhoo SK. Hyperglycemia in the critically ill patient. AACN Clin Issues 2006;17:50-5.
  • 26. Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immuno modulation in sepsis. Intensive Care Med 2004;30:748-56.
  • 27. McGuinness OP. Defective glucose homeostasis during infection. Annu Rev Nutr 2005;25:9-35.
  • 28. Hillenbrand A, Knippschild U, Weiss M, et al. Sepsis induced changes of adipokines and cytokines-septic patients compared to morbidly obese patients. BMC Surg 2010;10:26.
  • 29. Matsushita K, Tamakoshi K, Yatsuya. Further inflamatory information on metabolic syndrome by adiponectin evaluation. Internal J Cardiol 2007;1-6.
  • 30. Sandra G. Hassink, M.D. Obesity in kids Metabolic Footprint may be new measure. American Heart Association's 44th annual Conference on Cardiovascular Disease Epidemiology and Prevention. 2004.
  • 31. Krakoff J, Funahashi T, Stehouwer CD. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the pima indian. Diabetes Care 2003;26:1745-51.
  • 32. Xydakis AM, Case CC, Jones PH, et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 2004;89:2697-703.
  • 33. Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. In: Powell KR, editor. Infectious disease. 16 th ed. Philadelphia, W.B.Saunders Company 2000;736-8.
  • 34. Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett 2002;9:211-23.
  • 35. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 2007;380:24-30.
  • 36. Tang K, Zhang C, Zhang Y, et al. Sustained High Levels of Both Total and High Molecular Weight Adiponectin in Plasma During the Convalescent Phase of Haemorrhagic Fever With Renal Syndrome Are Associated With Disease Severity. J Immunol Res 2017;2017:6468097.
  • 37. Ozgen H, Ucar B, Yildirim A, et al.. Plasma Adiponectin Levels and Relations With Cytokines in Children With Acute Rheumatic Fever. Cardiol Young 2015;25:879- 92.
  • 38. Keskin G, Inal A, Ozışık L. Serum Adiponectin Levels in Patients With Familial Mediterranean Fever. Protein Pept Lett 2010;17:1258-62.
  • 39. Gerdan V, Sari I, Kozacı D, et al. Down-regulation of Adiponectin in Patients With Familial Mediterranean Fever During Attack-Free Period. Rheumatol Int 2012;32:2819-22.
  • 40. Takeshita S, Takabayashi H, Yoshida N. Circulating adiponectin levels in Kawasaki Disease. Clinical Observations 2006;1312-4.
APA Aydin B, KIREL B, SIRMAGÜL B (2021). Serum adiponectin levels in children with nonspecificinfections. , 1471 - 1476. 10.5455/annalsmedres.2020.09.922
Chicago Aydin Banu,KIREL BIRGÜL,SIRMAGÜL Başar Serum adiponectin levels in children with nonspecificinfections. (2021): 1471 - 1476. 10.5455/annalsmedres.2020.09.922
MLA Aydin Banu,KIREL BIRGÜL,SIRMAGÜL Başar Serum adiponectin levels in children with nonspecificinfections. , 2021, ss.1471 - 1476. 10.5455/annalsmedres.2020.09.922
AMA Aydin B,KIREL B,SIRMAGÜL B Serum adiponectin levels in children with nonspecificinfections. . 2021; 1471 - 1476. 10.5455/annalsmedres.2020.09.922
Vancouver Aydin B,KIREL B,SIRMAGÜL B Serum adiponectin levels in children with nonspecificinfections. . 2021; 1471 - 1476. 10.5455/annalsmedres.2020.09.922
IEEE Aydin B,KIREL B,SIRMAGÜL B "Serum adiponectin levels in children with nonspecificinfections." , ss.1471 - 1476, 2021. 10.5455/annalsmedres.2020.09.922
ISNAD Aydin, Banu vd. "Serum adiponectin levels in children with nonspecificinfections". (2021), 1471-1476. https://doi.org/10.5455/annalsmedres.2020.09.922
APA Aydin B, KIREL B, SIRMAGÜL B (2021). Serum adiponectin levels in children with nonspecificinfections. Annals of Medical Research, 28(8), 1471 - 1476. 10.5455/annalsmedres.2020.09.922
Chicago Aydin Banu,KIREL BIRGÜL,SIRMAGÜL Başar Serum adiponectin levels in children with nonspecificinfections. Annals of Medical Research 28, no.8 (2021): 1471 - 1476. 10.5455/annalsmedres.2020.09.922
MLA Aydin Banu,KIREL BIRGÜL,SIRMAGÜL Başar Serum adiponectin levels in children with nonspecificinfections. Annals of Medical Research, vol.28, no.8, 2021, ss.1471 - 1476. 10.5455/annalsmedres.2020.09.922
AMA Aydin B,KIREL B,SIRMAGÜL B Serum adiponectin levels in children with nonspecificinfections. Annals of Medical Research. 2021; 28(8): 1471 - 1476. 10.5455/annalsmedres.2020.09.922
Vancouver Aydin B,KIREL B,SIRMAGÜL B Serum adiponectin levels in children with nonspecificinfections. Annals of Medical Research. 2021; 28(8): 1471 - 1476. 10.5455/annalsmedres.2020.09.922
IEEE Aydin B,KIREL B,SIRMAGÜL B "Serum adiponectin levels in children with nonspecificinfections." Annals of Medical Research, 28, ss.1471 - 1476, 2021. 10.5455/annalsmedres.2020.09.922
ISNAD Aydin, Banu vd. "Serum adiponectin levels in children with nonspecificinfections". Annals of Medical Research 28/8 (2021), 1471-1476. https://doi.org/10.5455/annalsmedres.2020.09.922